Published in Proc Natl Acad Sci U S A on December 01, 1990
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev (2008) 4.49
Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing. Nucleic Acids Res (2001) 2.70
GABAA receptor trafficking-mediated plasticity of inhibitory synapses. Neuron (2011) 2.05
Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol Cell Biol (2003) 2.00
Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB. RNA (1999) 1.78
Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A (1998) 1.58
A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res (1994) 1.50
The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit. Proc Natl Acad Sci U S A (1994) 1.48
GABAA receptors are expressed and facilitate relaxation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2008) 1.43
Ca(2+)-induced rebound potentiation of gamma-aminobutyric acid-mediated currents requires activation of Ca2+/calmodulin-dependent kinase II. Proc Natl Acad Sci U S A (1996) 1.33
CaMKII phosphorylation of the GABA(A) receptor: receptor subtype- and synapse-specific modulation. J Physiol (2009) 1.11
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A (1998) 1.11
The third gamma subunit of the gamma-aminobutyric acid type A receptor family. Proc Natl Acad Sci U S A (1992) 1.05
Complex control of GABA(A) receptor subunit mRNA expression: variation, covariation, and genetic regulation. PLoS One (2012) 1.04
Neurologic effects of alcoholism. West J Med (1994) 1.01
Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the gamma2 subunit of the gamma-aminobutyrate type A receptor. Neuropharmacology (1999) 1.01
The GABAA receptors. Biochem J (1995) 1.00
The influence of the gamma 2L subunit on the modulation of responses to GABAA receptor activation. Br J Pharmacol (1993) 0.98
Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization. Neuroscience (2007) 0.98
Stable expression of mammalian type A gamma-aminobutyric acid receptors in mouse cells: demonstration of functional assembly of benzodiazepine-responsive sites. Proc Natl Acad Sci U S A (1992) 0.96
Consequences of the evolution of the GABA(A) receptor gene family. Cell Mol Neurobiol (2005) 0.96
High-resolution mapping of the gamma-aminobutyric acid receptor subunit beta 3 and alpha 5 gene cluster on chromosome 15q11-q13, and localization of breakpoints in two Angelman syndrome patients. Am J Hum Genet (1993) 0.96
GABAA receptors, anesthetics and anticonvulsants in brain development. CNS Neurol Disord Drug Targets (2008) 0.95
Preferential accumulation of GABAA receptor gamma 2L, not gamma 2S, cytoplasmic loops at rat spinal cord inhibitory synapses. J Physiol (2004) 0.95
Two forms of acetylcholine receptor gamma subunit in mouse muscle. Proc Natl Acad Sci U S A (1995) 0.90
GABA(A) receptors in normal development and seizures: friends or foes? Curr Neuropharmacol (2008) 0.90
Ethanol, gamma-aminobutyrate type A receptors, and protein kinase C phosphorylation. Proc Natl Acad Sci U S A (1995) 0.88
Alternative mRNA splice variants of the rat ClC-2 chloride channel gene are expressed in lung: genomic sequence and organization of ClC-2. Nucleic Acids Res (1997) 0.87
GABA(A) receptor epsilon-subunit may confer benzodiazepine insensitivity to the caudal aspect of the nucleus tractus solitarii of the rat. J Physiol (2001) 0.86
The pharmacology of recombinant GABAA receptors containing bovine alpha 1, beta 1, gamma 2L sub-units stably transfected into mouse fibroblast L-cells. Br J Pharmacol (1992) 0.86
Cloning and functional expression of alternative spliced variants of the rho1 gamma-aminobutyrate receptor. Proc Natl Acad Sci U S A (1998) 0.84
Impaired surface αβγ GABA(A) receptor expression in familial epilepsy due to a GABRG2 frameshift mutation. Neurobiol Dis (2012) 0.84
Molecular mechanisms supporting a paracrine role of GABA in rat adrenal medullary cells. J Physiol (2008) 0.84
Flavonoids as GABAA receptor ligands: the whole story? J Exp Pharmacol (2012) 0.82
Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes. Neuroscience (2010) 0.82
The short splice variant of the gamma 2 subunit acts as an external modulator of GABA(A) receptor function. J Neurosci (2010) 0.81
Regulation of GABAARs by phosphorylation. Adv Pharmacol (2014) 0.81
Effects of gamma-HCH and delta-HCH on human recombinant GABA(A) receptors: dependence on GABA(A) receptor subunit combination. Br J Pharmacol (2001) 0.80
Gene expression of receptors and enzymes involved in GABAergic and glutamatergic neurotransmission in the CNS of rats behaviourally dependent on ethanol. Br J Pharmacol (2000) 0.79
Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain. Transl Psychiatry (2015) 0.78
The effects of midazolam and sevoflurane on the GABA(A) receptors with alternatively spliced variants of the γ2 subunit. Korean J Anesthesiol (2011) 0.77
Hormone-dependent regulation of GABAA receptor gamma subunit mRNAs in sexually dimorphic regions of the rat brain. Proc Biol Sci (1998) 0.77
Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures. ISRN Neurol (2013) 0.76
Alternative RNA splicing: contribution to pain and potential therapeutic strategy. Drug Discov Today (2016) 0.76
Eugenol inhibits the GABAA current in trigeminal ganglion neurons. PLoS One (2015) 0.75
Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene (1987) 17.98
RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res (1987) 14.53
Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family. Nature (1987) 5.12
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature (1989) 4.45
Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem (1986) 3.37
Structural and functional basis for GABAA receptor heterogeneity. Nature (1988) 2.65
Cerebellar GABAA receptor selective for a behavioural alcohol antagonist. Nature (1990) 2.50
Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron (1989) 2.38
Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science (1989) 2.28
Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem (1990) 2.09
GABAA receptor beta subunit heterogeneity: functional expression of cloned cDNAs. EMBO J (1989) 2.05
Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature (1990) 2.04
Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature (1990) 1.84
The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J (1989) 1.79
A novel alpha subunit in rat brain GABAA receptors. Neuron (1989) 1.51
Transient expression shows ligand gating and allosteric potentiation of GABAA receptor subunits. Science (1988) 1.50
Cloning and expression of bovine brain inositol monophosphatase. J Biol Chem (1990) 1.41
Structure linkage, and sequence of the two genes encoding the delta and gamma subunits of the nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (1984) 1.40
Role of protein phosphorylation in neuronal signal transduction. FASEB J (1989) 1.31
Agents that activate protein kinase C reduce acetylcholine sensitivity in cultured myotubes. J Cell Biol (1985) 1.29
Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol Biochem Behav (1979) 1.19
The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon. EMBO J (1990) 1.15
Sequence and expression of a novel GABAA receptor alpha subunit. FEBS Lett (1989) 1.10
Protein kinase C and cAMP-dependent protein kinase phosphorylate the beta subunit of the purified gamma-aminobutyric acid A receptor. Proc Natl Acad Sci U S A (1990) 0.99
A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus. Nature (1990) 0.99
Functional expression and sites of gene transcription of a novel alpha subunit of the GABAA receptor in rat brain. FEBS Lett (1990) 0.92
Phosphorylation of the acetylcholine receptor by protein kinase C and identification of the phosphorylation site within the receptor delta subunit. J Biol Chem (1987) 0.91
Light and electron microscopic localization of beta I-, beta II-, and gamma-subspecies of protein kinase C in rat cerebral neocortex. J Neurosci (1990) 0.85
Protein kinase C modulates neurotransmitter responses in Xenopus oocytes injected with rat brain RNA. Brain Res Mol Brain Res (1989) 0.83
Heterogeneity of brain benzodiazepine receptors: effects of physiological conditions. Brain Res Bull (1985) 0.80
Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem (1966) 7.91
The uptake of [3H]GABA by slices of rat cerebral cortex. J Neurochem (1968) 5.05
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A (1986) 3.97
Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol (1971) 3.82
Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J Neurochem (1970) 3.42
The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol (1969) 3.25
Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. Br J Pharmacol (1970) 3.07
Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature (1977) 2.74
The retrograde axonal transport of nerve growth factor. Brain Res (1974) 2.60
Release of gamma-aminobutyric acid from inhibitory nerves of lobster. Proc Natl Acad Sci U S A (1966) 2.47
Multiple opiate receptor sites on primary afferent fibres. Nature (1980) 2.34
The possible existence of multiple receptors for substance P. Naunyn Schmiedebergs Arch Pharmacol (1982) 2.18
Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J Neurosci (1997) 2.08
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03
GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors. J Neurochem (1971) 2.00
Trans-synaptic regulation of growth and development of adrenergic neurones in a mouse sympathetic ganglion. Brain Res (1971) 1.99
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A (1988) 1.99
Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus. Mol Pharmacol (1999) 1.96
Release of dopamine from dendrites in rat substantia nigra. Nature (1976) 1.95
Reduced uptake of tritiated noradrenaline in tissues of immunosympathectomized animals. Nature (1965) 1.91
Autoradiographic localization of 3 H-GABA in rat retina. Nat New Biol (1972) 1.90
Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Br J Pharmacol (1969) 1.90
Multiple tachykinin binding sites in peripheral tissues and in brain. Eur J Pharmacol (1986) 1.86
Catecholamine uptake processes. Br Med Bull (1973) 1.83
Uptake and metabolism of gamma-aminobutyric acid by neurones and glial cells. Biochem Pharmacol (1975) 1.83
The inhibition of noradrenaline uptake by drugs. Adv Drug Res (1965) 1.82
Use of catechol O-methyltransferase for the enzyme radiochemical assay of dopamine. J Neurochem (1973) 1.82
Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res (1978) 1.80
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A (1994) 1.79
Dopamine receptors in the brain. Science (1975) 1.79
Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78
Uptake mechanisms for neurotransmitter amines. Biochem Pharmacol (1974) 1.73
Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann N Y Acad Sci (1999) 1.71
Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. Eur J Pharmacol (1983) 1.65
Sodium dependence of transmitter uptake at adrenergic nerve terminals. Mol Pharmacol (1966) 1.63
A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain (1982) 1.62
The release of gamma-aminobutyric acid during inhibition in the cat visual cortex. J Physiol (1971) 1.59
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. J Pharmacol Exp Ther (1967) 1.58
Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain (1974) 1.57
theta, a novel gamma-aminobutyric acid type A receptor subunit. Proc Natl Acad Sci U S A (1999) 1.54
Differences in the regulation of tyrosine hydroxylase and dopa decarboxylase in sympathetic ganglia and adrenals. Nat New Biol (1971) 1.54
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience (1981) 1.50
alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J Biol Chem (2001) 1.48
A quantitative ultrastructural and biochemical analysis of the process of reinnervation of the superior cervical ganglion in the adult rat. Brain Res (1974) 1.43
Structure and pharmacology of vertebrate GABAA receptor subtypes. Int Rev Neurobiol (1995) 1.42
A novel allosteric modulatory site on the GABAA receptor beta subunit. Neuron (1994) 1.41
Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer. J Biol Chem (1999) 1.41
Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol (1978) 1.38
Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. J Neurosci (2001) 1.37
Smoking...harmful to the brain. Nature (1996) 1.37
Enhancement of H-3-norepinephrine uptake in rat tissues by O-methylated metabolites of catecholamines. J Pharmacol Exp Ther (1966) 1.36
Subcellular distribution of endogenous and (3H) gamma-aminobutyric acid in rat cerebral cortex. J Neurochem (1969) 1.35
The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. J Pharmacol Exp Ther (1965) 1.30
Age-related changes in GABA(A) receptor subunit composition and function in rat auditory system. Neuroscience (1999) 1.29
Effects of surgical decentralization and nerve growth factor on the maturation of adrenergic neurons in a mouse sympathetic ganglion. J Neurochem (1972) 1.28
Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor. J Pharmacol Exp Ther (2000) 1.26
Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux. Mol Pharmacol (2001) 1.26
Glycine uptake in rat central nervous system slices and homogenates: evidence for different uptake systems in spinal cord and cerebral cortex. J Neurochem (1971) 1.24
Release and metabolism of substance P in rat hypothalamus. Nature (1976) 1.24
Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem (1966) 1.23
Autoradiographic localization of alpha5 subunit-containing GABAA receptors in rat brain. Brain Res (1999) 1.23
Purification and characterisation of a membrane-bound substance-P-degrading enzyme from human brain. Eur J Biochem (1981) 1.22
[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit. Neuropharmacology (1996) 1.21
Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett (1980) 1.21
Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro. Nature (1978) 1.21
Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain. Nature (1969) 1.20
Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proc Natl Acad Sci U S A (1992) 1.19
The metabolism of gamma-aminobutyric acid (GABA) in the lobster nervous system--uptake of GABA in the nerve-muscle preparations. J Neurochem (1968) 1.19
Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci (1983) 1.18
Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther (1966) 1.18
Studies of the uptake of 3 H-gaba and ( 3 H)glycine in slices and homogenates of rat brain and spinal cord by electron microscopic autoradiography. Brain Res (1972) 1.18
Mechanism of inositol monophosphatase, the putative target of lithium therapy. Proc Natl Acad Sci U S A (1994) 1.18
Localizing 3H-GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography. Nature (1971) 1.18
Noradrenaline metabolizing enzymes in normal and sympathetically denervated vas deferens. J Neurochem (1971) 1.12
Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci Lett (1983) 1.12
The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem (1994) 1.12
Tyrosine kinase phosphorylation of GABAA receptors. Brain Res Mol Brain Res (1995) 1.11
A quantitative comparison of the formation of synapses in the rat superior cervical sympathetic ganglion by its own and by foreign nerve fibres. Brain Res (1976) 1.10
The role of post-synaptic neurones in the biochemical maturation of presynaptic cholinergic nerve terminals in a mouse sympathetic ganglion. J Physiol (1972) 1.10
Effects of protriptyline on the depletion of catecholamines induced by 6-hydroxydopamine in the brain of the rat. J Pharm Pharmacol (1970) 1.10
Release of (3H)gamma-aminobutyric acid from glial cells in rat dorsal root ganglia. J Neurochem (1974) 1.09
Metabolism of alpha- and beta-adrenergic receptors in vitro and in vivo. Annu Rev Pharmacol Toxicol (1987) 1.09
The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: A novel catechol amine uptake process. Br J Pharmacol Chemother (1965) 1.08
Synaptosomes: different populations storing catecholamines and gamma-aminobutyric acid in homogenates of rat brain. Nature (1968) 1.08
Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro. Nature (1977) 1.08
Trans-synaptic regulation of tyrosine hydroxylase activity in adrenergic neurones: effect of potassium concentration on cultured sympathetic ganglia. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.06
Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord (1987) 1.06
Neuronal uptake processes for amines and amino acids. Adv Biochem Psychopharmacol (1970) 1.05
The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes. Neurosci Lett (1982) 1.05
Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors. Br J Pharmacol (1988) 1.05
Thermoregulation: effects of environmental temperature on turnover of hypothalamic norepinephrine. Science (1969) 1.03
Modification of an enzyme radiochemical assay procedure for noradrenaline. Biochem Pharmacol (1970) 1.02
Differences in the uptake, storage and metabolism of (+)- and (-)-noradrenaline. Br J Pharmacol (1971) 1.02
Effect of chlorpromazine and some of its metabolites on the dopamine-sensitive adenylate cyclase of rat brain striatum. J Pharm Pharmacol (1974) 1.02
Catecholamine-sensitive adenylate cyclases in nervous tissues. J Neurochem (1977) 1.02
Model of subunit composition of gamma-aminobutyric acid A receptor subtypes expressed in rat cerebellum with respect to their alpha and gamma/delta subunits. J Biol Chem (1994) 1.01
Substance P. J Med Chem (1982) 1.01
Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. Mol Pharmacol (1976) 1.00
Inhibition of the extraneuronal metabolism of noradrenaline in the isolated heart by adrenergic blocking agents. Nature (1967) 1.00
Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495). Naunyn Schmiedebergs Arch Pharmacol (1974) 1.00